Parkinson’s disease therapy
Nov 18, 2024
The Future of Parkinson’s Disease Treatment: Unlocking the Potential of Cell and Gene Therapy
Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It affects about 10 million people worldwide. The average age of onset for Parkinson’s disease is around 60; however, approximately 10-15% of patients experience early-onset PD before the age of 50. In 2023, there...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
